Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-84.48	8.76	56.46
Graham Fair Price	179.58	24.78	8.86
PEG	-98.62	< 0.005	-0.41
Price/Book	-14.33	0.79	0.92
Price/Cash Flow	-28.53	-8.39	11.73
Prices/Earnings	-87.78	3.70	30.29
Price/Sales	-31.67	1.26	1.85
Price/FCF	-28.53	-8.39	11.73
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	52.41	0.22	0.15
Operating Margin	407.94	0.11	0.02
ROA	639.41	0.02	< 0.005
ROE	< 0.005	0.05	601.18
ROIC	< 0.005	0.04	458.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.16	-0.03	479.32
Dividends QOQ	-0.57	-0.32	44.08
EBIT QOQ	-0.70	5.73	715.74
EPS QOQ	-0.73	6.50	786.36
FCF QOQ	1.19	-2.27	89.72
Revenue QOQ	-0.05	0.32	568.08
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	69.91	49.61	-29.04
Days Sales Outstanding (DSO)	110.58	96.76	-12.50
Inventory Turnover	1.29	1.81	40.92
Debt/Capitalization	0.25	0.27	6.82
Quick Ratio	1.18	1.30	10.74
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	21.48	22.68	5.58
Cash	13.11	12.15	-7.32
Capex	-0.29	-0.20	32.38
Free Cash Flow	1.68	-2.13	26.56
Revenue	10.66	14.11	32.37
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.55	1.64	6.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-23.29	-2.26	90.28
Naive Interpretation	Member

06 - Financial Health · Weak

Rating